Microsoft Announces Plans to Buy Human Gene Editing Company Crispr Therapeutics for $9.85 Billion

223

report

Microsoft announced that it will acquire Crispr Therapeutics, a gene editing company, in a US$9.85 billion (CHF9.03 billion) cash deal.

Comments (5) 10023 👁️